REGONOL (pyridostigmine bromide)
ANTIMYASTHENIC AGENTS·MYASTHENIA GRAVIS·+1
SANDOZ
Indication
Reversal of neuromuscular blockade induced by nondepolarizing drug
Reversal of neuromuscular blockade induced by nondepolarizing drug refers to the targeted restoration of normal skeletal muscle function and endogenous neuromuscular transmission following the administration of nondepolarizing neuromuscular blocking agents during anesthesia or critical care. Read more about Reversal of neuromuscular blockade induced by nondepolarizing drug
2 drugs 2 manufacturers
Drugs that treat it
Common Reversal of neuromuscular blockade induced by nondepolarizing drug therapies.
ENLON-PLUS (edrophonium chloride/atropine sulfate)
REVERSAL OF NEUROMUSCULAR BLOCKADE INDUCED BY NONDEPOLARIZING DRUG
BIONICHE PHARMA
Filter & compare in the drug finder →Opens the drug finder with Reversal of neuromuscular blockade induced by nondepolarizing drug preselected.
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonReversal of neuromuscular blockade induced by nondepolarizing drug refers to the targeted restoration of normal skeletal muscle function and endogenous neuromuscular transmission following the administration of nondepolarizing neuromuscular blocking agents during anesthesia or critical care.
It addresses an iatrogenic state characterized by pharmacologic flaccid paralysis affecting the peripheral motor system, including respiratory, pharyngeal, and skeletal musculature.
Pathophysiologically, competitive antagonism of postjunctional nicotinic acetylcholine receptors at the motor endplate impedes muscle contraction; reversal counteracts this blockade to resolve or prevent residual neuromuscular weakness, hypoventilation, and upper airway compromise upon emergence.
- nih.gov
Reversal of neuromuscular blockade induced by nondepolarizing drug refers to the targeted restoration of normal skeletal muscle function and endogenous neuromuscular transmission following the administration of nondepolarizing neuromuscular blocking agents during anesthesia or critical care It addresses an iatrogenic state characterized by pharmacologic flaccid paralysis affecting the peripheral motor system, including respiratory, pharyngeal, and skeletal musculature Pathophysiologically, compe...
- nih.gov
Reversal of neuromuscular blockade induced by nondepolarizing drug refers to the targeted restoration of normal skeletal muscle function and endogenous neuromuscular transmission following the administration of nondepolarizing neuromuscular blocking agents during anesthesia or critical care
- nih.gov
It addresses an iatrogenic state characterized by pharmacologic flaccid paralysis affecting the peripheral motor system, including respiratory, pharyngeal, and skeletal musculature Pathophysiologically, competitive antagonism of postjunctional nicotinic acetylcholine receptors at the motor endplate impedes muscle contraction; reversal counteracts this blockade to resolve or prevent residual neuromuscular weakness, hypoventilation, and upper airway compromise upon emergence
Personalize your experience
Follow Reversal of neuromuscular blockade induced by nondepolarizing drug and get updates as they land.
Create a free account
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.